Annual Retained Earnings
-$417.43 M
-$82.44 M-24.61%
31 December 2023
Summary:
Black Diamond Therapeutics annual retained earnings is currently -$417.43 million, with the most recent change of -$82.44 million (-24.61%) on 31 December 2023. During the last 3 years, it has fallen by -$299.21 million (-253.08%). BDTX annual retained earnings is now -6055.89% below its all-time high of -$6.78 million, reached on 31 December 2017.BDTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$471.12 M
-$15.56 M-3.41%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly retained earnings is currently -$471.12 million, with the most recent change of -$15.56 million (-3.41%) on 30 September 2024. Over the past year, it has dropped by -$73.10 million (-18.37%). BDTX quarterly retained earnings is now -2898.49% below its all-time high of -$15.71 million, reached on 31 December 2018.BDTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -24.6% | -18.4% |
3 y3 years | -253.1% | -116.2% |
5 y5 years | -2556.8% | -1046.4% |
BDTX Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -253.1% | at low | -116.2% | at low |
5 y | 5 years | -2556.8% | at low | -1046.4% | at low |
alltime | all time | -6055.9% | at low | -2898.5% | at low |
Black Diamond Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$471.12 M(+3.4%) |
June 2024 | - | -$455.56 M(+4.6%) |
Mar 2024 | - | -$435.66 M(+4.4%) |
Dec 2023 | -$417.43 M(+24.6%) | -$417.43 M(+4.9%) |
Sept 2023 | - | -$398.02 M(+6.1%) |
June 2023 | - | -$375.02 M(+5.4%) |
Mar 2023 | - | -$355.86 M(+6.2%) |
Dec 2022 | -$334.99 M(+37.4%) | -$334.99 M(+6.7%) |
Sept 2022 | - | -$313.91 M(+7.4%) |
June 2022 | - | -$292.26 M(+8.5%) |
Mar 2022 | - | -$269.33 M(+10.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | -$243.82 M(+106.2%) | -$243.82 M(+11.9%) |
Sept 2021 | - | -$217.95 M(+19.2%) |
June 2021 | - | -$182.88 M(+23.1%) |
Mar 2021 | - | -$148.53 M(+25.6%) |
Dec 2020 | -$118.22 M(+131.9%) | -$118.22 M(+23.7%) |
Sept 2020 | - | -$95.60 M(+23.1%) |
June 2020 | - | -$77.69 M(+23.1%) |
Mar 2020 | - | -$63.12 M(+23.8%) |
Dec 2019 | -$50.97 M(+224.4%) | -$50.97 M(+24.0%) |
Sept 2019 | - | -$41.09 M(+161.6%) |
Dec 2018 | -$15.71 M(+131.7%) | -$15.71 M |
Dec 2017 | -$6.78 M | - |
FAQ
- What is Black Diamond Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual retained earnings year-on-year change?
- What is Black Diamond Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly retained earnings year-on-year change?
What is Black Diamond Therapeutics annual retained earnings?
The current annual retained earnings of BDTX is -$417.43 M
What is the all time high annual retained earnings for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual retained earnings is -$6.78 M
What is Black Diamond Therapeutics annual retained earnings year-on-year change?
Over the past year, BDTX annual retained earnings has changed by -$82.44 M (-24.61%)
What is Black Diamond Therapeutics quarterly retained earnings?
The current quarterly retained earnings of BDTX is -$471.12 M
What is the all time high quarterly retained earnings for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly retained earnings is -$15.71 M
What is Black Diamond Therapeutics quarterly retained earnings year-on-year change?
Over the past year, BDTX quarterly retained earnings has changed by -$73.10 M (-18.37%)